Solana's price has rebounded from the $233.8 support level, forming a bullish double-bottom pattern that has attracted significant institutional interest. Over $28 million in SOL has been purchased near this level, indicating strong demand. In a major corporate move, Helius Medical Technologies has committed $500 million to adopt SOL as its primary treasury reserve, with plans to expand its holdings. These developments suggest a potential 82% rally to $457.97 if the current momentum and buying interest persist, supported by institutional and corporate activities.